inTRANSITION FAQs
Frequently Asked Questions
Tell us what you're looking for to find questions and answers about your topic.
Recent FAQs
inTRANSITION FAQs for Service Members and Veterans
Mental Health by the Numbers FAQs
Airborne Hazards and Open Burn Pit Registry: Eligibility and Enrollment
Airborne Hazards and Open Burn Pit Registry: General Information
Individual Longitudinal Exposure Record
MHS Modified Payment and Waiver Program: Overseas Information
MHS Modified Payment and Waiver Program: Implementation Timeline
MHS Modified Payment and Waiver Program: Billing Delays
MHS Modified Payment and Waiver Program: Eligibility Requirements
Popular FAQs
MHS GENESIS Patient Portal
Joint Longitudinal Viewer
Individual Longitudinal Exposure Record
Airborne Hazards and Open Burn Pit Registry: Eligibility and Enrollment
Remote Health Readiness Program: Service Member
VA/DOD Clinical Practice Guideline for Tinnitus
MHS GENESIS
TRICARE Formulary
Joint Health Information Exchange
Project 112 SHAD
We found 867 items
DOD P&T Committee Executive Summary: Emergency Contraceptive Agents
Executive Summary from the May 2016 P&T Committee meeting
P&T Minutes - May 2016
Minutes from the quarterly meetings of the DoD P&T Committee. Please note that files for the July 2004 and subsequent meetings contain both meeting minutes and the decision paper signed by the Director, Defense Health Agency, approving or disapproving the recommendations of the Committee.
BAP Handout: June 22, 2016
Handout for the June 22 BAP Meeting
BAP Background Information: June 22, 2016
Background Information for the June 22 BAP Meeting
BAP Agenda: June 22, 2016
Agenda for the June 22 BAP Meeting
P&T Meetings 2015
Cumulative Minutes from the DoD P&T Committee Meetings for 2015
Pre-Proposal Meeting Minutes May 2016
Pre-Proposal Meeting Minutes May 2016
Minutes: June 2, 2016
Minutes for the DHB meeting on June 2, 2016
Agenda: June 2, 2016
Agenda for the DHB meeting on June 2, 2016
DOD P&T Committee Executive Summary: Contraceptive Agents
DOD Subclass Review: Oral and Miscellaneous Contraceptives Feb. 2016
DOD P&T Committee Executive Summary: Ophthalmic Immunomodulatory Agents Cyclosporine 0.05% Ophthalmic Emulsion (Restasis)
DOD Subclass Review: Ophthalmic Immunomodulatory Agents: Restatis February 2016
DOD P&T Committee Executive Summary: Topical Antifungal Drugs for Onychomycosis
DOD Subclass Review: Topical Antifungal Drugs for Onychomycosis Feb. 2016
P&T Minutes - February 2016
P&T Committee Meeting minutes for February 2016
BAP Background Information: April 6, 2016
Meeting Materials for the 6 APR 16 UF BAP meeting.
BAP Handout: April 6, 2016
Meeting Materials for the 6 April 16 UF BAP Meeting
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil View the external links disclaimer.